p.114 抽出テキスト

of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011;32:2125–34. https://doi.org/10.1093/eurheartj/ehr213 819. Makikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IBA, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, openlabel, non-inferiority trial. Lancet 2016;388:2743–52. https://doi.org/10.1016/S0140- 6736(16)32052-9 820. Holm NR, Makikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet 2020;395:191–9. https://doi.org/10.1016/ S0140-6736(19)32972-1 821. Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 2016;375:2223–35. https://doi.org/10.1056/NEJMoa1610227 822. Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, et al. Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med 2019;381: 1820–30. https://doi.org/10.1056/NEJMoa1909406 823. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629–38. https://doi.org/ 10.1016/S0140-6736(13)60141-5 824. Farkouh ME, Domanski M, Dangas GD, Godoy LC, Mack MJ, Siami FS, et al. Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study. J Am Coll Cardiol 2019;73:629–38. https://doi.org/10. 1016/j.jacc.2018.11.001 825. Parasca CA, Head SJ, Milojevic M, Mack MJ, Serruys PW, Morice MC, et al. Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the SYNTAX trial at 5 years. JACC Cardiovasc Interv 2016;9:2493–507. https://doi.org/10.1016/j.jcin. 2016.09.044 826. van Nunen LX, Zimmermann FM, Tonino PA, Barbato E, Baumbach A, Engstrøm T, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet 2015;386:1853–60. https://doi.org/10.1016/S0140-6736(15) 00057-4 827. Zimmermann FM, Ding VY, Pijls NHJ, Piroth Z, van Straten AHM, Szekely L, et al. Fractional flow reserve-guided pci or coronary bypass surgery for 3-vessel coronary artery disease: 3-year follow-up of the FAME 3 trial. Circulation 2023;148:950–8. https://doi.org/10.1161/CIRCULATIONAHA.123.065770 828. Piroth Z, Otsuki H, Zimmermann FM, Ferenci T, Keulards DCJ, Yeung AC, et al. Prognostic value of measuring fractional flow reserve after percutaneous coronary intervention in patients with complex coronary artery disease: insights from the FAME 3 trial. Circ Cardiovasc Interv 2022;15:884–91. https://doi.org/10.1161/ CIRCINTERVENTIONS.122.012542 829. Collison D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, McDade R, McCartney P, et al. Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR). Eur Heart J 2021;42: 4656–68. https://doi.org/10.1093/eurheartj/ehab449 830. Patel MR, Jeremias A, Maehara A, Matsumura M, Zhang Z, Schneider J, et al. 1-Year outcomes of blinded physiological assessment of residual ischemia after successful PCI: DEFINE PCI trial. JACC Cardiovasc Interv 2022;15:52–61. https://doi.org/10. 1016/j.jcin.2021.09.042 831. Hwang D, Koo BK, Zhang J, Park J, Yang S, Kim M, et al. Prognostic implications of fractional flow reserve after coronary stenting: a systematic review and meta-analysis. JAMA Netw Open 2022;5:e2232842. https://doi.org/10.1001/jamanetworkopen.2022. 32842 832. Collet C, Johnson Nils P, Mizukami T, Fearon WF, Berry C, Sonck J, et al. Impact of post-PCI FFR stratified by coronary artery. JACC Cardiovasc Interv 2023;16: 2396–408. https://doi.org/10.1016/j.jcin.2023.08.018 833. Dai N, Yuan S, Dou K, Zhang R, Hu N, He J, et al. Prognostic implications of prestent pullback pressure gradient and poststent quantitative flow ratio in patients undergoing percutaneous coronary intervention. J Am Heart Assoc 2022;11:e024903. https://doi. org/10.1161/JAHA.121.024903 834. Dai N, Tang X, Chen Z, Huang D, Duan S, Qian J, et al. Pre-stenting angiography-FFR based physiological map provides virtual intervention and predicts physiological and clinical outcomes. Catheter Cardiovasc Interv 2023;101:1053–61. https://doi.org/10. 1002/ccd.30635 835. Kikuta Y, Cook CM, Sharp ASP, Salinas P, Kawase Y, Shiono Y, et al. Pre-angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease: primary results of the international multicenter iFR GRADIENT registry. JACC Cardiovasc Interv 2018;11:757–67. https://doi.org/10.1016/ j.jcin.2018.03.005 836. Biscaglia S, Verardi FM, Tebaldi M, Guiducci V, Caglioni S, Campana R, et al. QFR-based virtual PCI or conventional angiography to guide PCI: the AQVA trial. JACC Cardiovasc Interv 2023;16:783–94. https://doi.org/10.1016/j.jcin.2022.10.054 837. Bouisset F, Ohashi H, Andreini D, Collet C. (September 19, 2023) Role of coronary computed tomography angiography to optimise percutaneous coronary intervention outcomes. Heart 2024;110:1056–1062 838. Sonck J, Nagumo S, Norgaard BL, Otake H, Ko B, Zhang J, et al. Clinical validation of a virtual planner for coronary interventions based on coronary CT angiography. JACC Cardiovasc Imaging 2022;15:1242–55. doi: doi:10.1016/j.jcmg.2022.02.003 839. Van Belle E, Raposo L, Bravo Baptista S, Vincent F, Porouchani S, Cosenza A, et al. Impact of an interactive CT/FFR(CT) interventional planner on coronary artery disease management decision making. JACC Cardiovasc Imaging 2021;14:1068–70. https://doi.org/10.1016/j.jcmg.2020.09.040 840. Lee JM, Choi KH, Song YB, Lee JY, Lee SJ, Lee SY, et al. Intravascular imaging-guided or angiography-guided complex PCI. N Engl J Med 2023;388:1668–79. https://doi.org/10. 1056/NEJMoa2216607 841. Ali ZA, Landmesser U, Maehara A, Matsumura M, Shlofmitz RA, Guagliumi G, et al. Optical coherence tomography-guided versus angiography-guided PCI. N Engl J Med 2023;389:1466–76. https://doi.org/10.1056/NEJMoa2305861 842. Sabik JF III, Blackstone EH, Gillinov AM, Banbury MK, Smedira NG, Lytle BW. Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg 2006;131:90–8. https://doi.org/10.1016/j.jtcvs.2005.05.024 843. Locker C, Schaff HV, Dearani JA, Joyce LD, Park SJ, Burkhart HM, et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation 2012;126: 1023–30. https://doi.org/10.1161/CIRCULATIONAHA.111.084624 844. Lowenstern A, Wu J, Bradley SM, Fanaroff AC, Tcheng JE, Wang TY. Current landscape of hybrid revascularization: a report from the NCDR CathPCI Registry. Am Heart J 2019;215:167–77. https://doi.org/10.1016/j.ahj.2019.06.014 845. Ganyukov VI, Kochergin NA, Shilov AA, Tarasov RS, Skupien J, Kozyrin KA, et al. Randomized clinical trial of surgical versus percutaneous versus hybrid multivessel coronary revascularization: 3 years’ follow-up. JACC Cardiovasc Interv 2021;14:1163–5. https://doi.org/10.1016/j.jcin.2021.02.037 846. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns 2006;60:301–12. https://doi.org/10.1016/j.pec.2005.06. 010 847. Mulley AG, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients’ preferences matter. BMJ 2012;345:e6572. https://doi.org/10.1136/bmj.e6572 848. Hughes TM, Merath K, Chen Q, Sun S, Palmer E, Idrees JJ, et al. Association of shared decision-making on patient-reported health outcomes and healthcare utilization. Am J Surg 2018;216:7–12. https://doi.org/10.1016/j.amjsurg.2018.01.011 849. Nuis RJ, Jadoon A, van Dalen BM, Dulfer K, Snelder SM, Yazdi MT, et al. Patient perspectives on left main stem revascularization strategies, the OPINION-2 study. J Cardiol 2021;77:271–8. https://doi.org/10.1016/j.jjcc.2020.09.009 850. Oudkerk Pool MD, Hooglugt JQ, Schijven MP, Mulder BJM, Bouma BJ, de Winter RJ, et al. Review of digitalized patient education in cardiology: a future ahead? Cardiology 2021;146:263–71. https://doi.org/10.1159/000512778 851. Lincoln TE, Buddadhumaruk P, Arnold RM, Scheunemann LP, Ernecoff NC, Chang CCH, et al. Association between shared decision-making during family meetings and surrogates’ trust in their ICU physician. Chest 2023;163:1214–24. https://doi.org/10. 1016/j.chest.2022.10.028 852. Ayton DR, Barker AL, Peeters G, Berkovic DE, Lefkovits J, Brennan A, et al. Exploring patient-reported outcomes following percutaneous coronary intervention: a qualitative study. Health Expect 2018;21:457–65. https://doi.org/10.1111/hex.12636 853. Kipp R, Lehman J, Israel J, Edwards N, Becker T, Raval AN. Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease. Catheter Cardiovasc Interv 2013;82:212–8. https://doi.org/10.1002/ccd. 24399 854. Witberg G, Segev A, Barac YD, Raanani E, Assali A, Finkelstein A, et al. Heart team/ guidelines discordance is associated with increased mortality: data from a national survey of revascularization in patients with complex coronary artery disease. Circ Cardiovasc Interv 2021;14:e009686. https://doi.org/10.1161/circinterventions.120. 009686 855. Patterson T, McConkey HZR, Ahmed-Jushuf F, Moschonas K, Nguyen H, Karamasis GV, et al. Long-term outcomes following heart team revascularization recommendations in complex coronary artery disease. J Am Heart Assoc 2019;8:e011279. https://doi. org/10.1161/jaha.118.011279 856. Jonik S, Marchel M, Huczek Z, Kochman J, Wilimski R, Kuśmierczyk M, et al. An individualized approach of multidisciplinary heart team for myocardial revascularization and valvular heart disease—state of art. J Pers Med 2022;12:705. https://doi.org/10. 3390/jpm12050705 857. McKeown L, Hong YA, Kreps GL, Xue H. Trends and differences in perceptions of patient-centered communication among adults in the US. Patient Educ Couns 2023; 106:128–34. https://doi.org/10.1016/j.pec.2022.10.010 858. Tsang MB, Schwalm JD, Gandhi S, Sibbald MG, Gafni A, Mercuri M, et al. Comparison of heart team vs interventional cardiologist recommendations for the treatment of Downloaded from academic.oup.com/eurheartj/article/45/36/3415/7743115 by guest on 07 October 2026